Serum galectin-3 levels in patients with nonalcoholic fatty liver disease.

@article{Yilmaz2011SerumGL,
  title={Serum galectin-3 levels in patients with nonalcoholic fatty liver disease.},
  author={Yusuf Yilmaz and Fatih Eren and Ramazan Kurt and Oya Yonal and Zulfikar Polat and Ebubekir Şenateş and Mohammad Bacha and Nese Imeryuz},
  journal={Clinical biochemistry},
  year={2011},
  volume={44 12},
  pages={955-8}
}
OBJECTIVES Galectin-3 might serve as a biomarker of human metabolic alterations. We measured serum levels of galectin-3 in patients with nonalcoholic fatty liver disease (NAFLD) and examined their association with clinical and histological phenotypes. DESIGN AND METHODS Serum levels of galectin-3 were assayed in 71 patients with biopsy-proven NAFLD and 39 controls. RESULTS Serum galectin-3 levels did not differ in patients with NAFLD (median 4.1 ng/mL; interquartile range: 1.5-5.5 ng/mL… CONTINUE READING